This is a case report on intrapartum use of recombinant factor VIIa (rFVIIa) in a pregnant woman with factor VII deficiency (1%), leading to normalization of a prolonged prothrombin time with no excessive bleeding. The paper also presents a literature review on treatment of factor VII deficiency and the use of rFVIIa in pregnancy.
– M. Aldouri
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther heathcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Follow us
Subscribe to our newsletter
- Tutorials
- Resources
- Guides
- Examples
- Docs